Chemists have long been fascinated and frustrated by saxitoxin: a molecule that causes temporary paralysis by blocking the ...
Ascletis Pharma Inc. (HKEX: 1672, "Ascletis") announces today positive topline results in its 13-week Phase II study evaluating ASC30, an oral small molecule GLP-1 receptor (GLP-1R) agonist for the ...
Evercore 8th Annual Healthcare Conference December 3, 2025 10:50 AM ESTCompany ParticipantsDietmar Berger - Chief ...
Free radicals have a terrible reputation. These reactive and unstable molecules have been associated with cancer, aging, and degenerative diseases such as Alzheimer's. Yet the body constantly produces ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results